Humanized CD19 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With B-cell Malignancies
Clinical trial NCT04008251 · UNKNOWN
Trial details
- NCT number
- NCT04008251
- Sponsor
- Wuhan Sian Medical Technology Co., Ltd
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-27
- Primary completion
- 2022-07-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.